Jasper Therapeutics, Inc.

US$16.86As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:JSPRHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (53.39%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 3.31
PE TTM —
TSR TTM (75.35%)
Mkt cap US$18.70M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$19
13.88%
(28.52%)
Hold 10|11|3|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.19
0.19
0.19
8.17%
17.88%
13.11%
6.01%
Revenue$M
1.398
1.389
1.461
1.443
8.01%
3.52%
5.16%
6.42%
Peers (US$18.70M)
Cap (US$)
PE
17.91M
—
18.87M
1,929x
Capital
TTM
5Y
10Y
Leveragex
5.908
0.305
0.289
EBIT/Intx
1.864
4.607
3.750
Own earn%
88.33
(10.24)
(9.05)
Sh yield%
41.09
17.17
16.79
Owners
Insiders/Inst%
3.78
48.39
Short interest%
2.48
SBC / revenue%
1.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
4